期刊文献+

胎儿染色体非整倍体无创检测在产前诊断中的应用价值 被引量:9

Clinical value of non-invasive prenatal test in detecting chromosome aneuploidy
暂未订购
导出
摘要 目的探讨胎儿染色体非整倍体无创检测在产前诊断中的应用价值。方法汇总2016年1月至12月在广州中山大学附属第一医院行无创产前检测(non-invasive prenatal testing,NIPT)的1 207例孕妇的检测结果及生育前后追踪随访结果,回顾性分析孕妇行NIPT的指征构成比以及评价NIPT分析性能。结果中山大学附属第一医院临床选择NIPT的指征主要是高龄妊娠(62.55%),其次是血清学筛查异常(25.85%)和不良孕产史(17.23%)。1 207例标本经基因测序检出胎儿染色体非整倍体异常高风险20例,其中21-三体综合征(21-trisomy syndrome,T21)高风险8例,18-三体综合征(18-trisomy syndrome,T18)高风险7例;经染色体核型分析确诊为T21和T18的例数分别为7例和5例。NIPT检测T21的平均Z值为6.710±2.122,95%置信区间(95%confidence interval,95%CI)为4.936~8.484;检测灵敏度为100%(7/7)、特异度为99.92%(1 199/1 200)、漏诊率为0(0/7)、误诊率为0.08%(1/1 200)、诊断准确度为99.92%(1 206/1 207)、阳性预测值为87.5%(7/8)、阴性预测值为100%(1 199/1 199)。检测T18的平均Z值为6.593±2.352,95%CI为4.418~8.768;检测灵敏度为100%(5/5)、特异度为99.83%(1 200/1 202)、漏诊率为0(0/5)、误诊率为0.17%(2/1 202)、诊断准确度为99.83%(1 205/1 207)、阳性预测值为71.43%(5/7)、阴性预测值为100%(1 200/1 200)。结论 NIPT检测胎儿染色体非整倍体异常快速、安全、准确,与染色体核型分析技术具有较高的一致性,在产前诊断中具有良好的临床应用价值。 Objective To explore the clinical value of non-invasive tecting chromosome aneuploidy. Method A total of ] 207 pregnant women prenatal testing (NIPT) in de- enrolled in the First Affiliated Hospital of Sun Yat-sen University who accepted NIPT for chromosomes 21, 18 and 13 from January to De- cember 2016 were analyzed and followed up with around childbirth retrospectively. Invasive prenatal diagnosis followed by fetal chromosome karyotype analysis was recommended in high-risk women following NIPT. The clinical indications and analysis capability of NIPT were examined. Results The most common indication for NIPT was advanced maternal age (62.55%), followed by serological screening abnormality (25.85%) and negative reproductive history (17.23%). 20 of 1 207 cases were detected with high-risk fetal abnormal chromosome aneuploidy, including 8 cases with 21-trisomy syndrome (T21), 7 cases with 18-trisomy syndrome (T18). 20 cases received amniotic cavity puncture karyotype analysis, the result showed 7 cases with T21 and 5 cases with T18. Comparing the results of NIPT and karyotype analysis, the average Z value for diagnosing T21 was 6.710___2.122, 95% confidence interval (95% C/) was 4.936-8.484, the sensitivity was 100% (7/7), the specific- ity was 99.92% (1 199/1 200), the missed diagnosis rate was 0 (0/7), the misdiagnosis rate was 0.08% (1/1 200), the accuracy rate was 99.92% (1 206/1 207), the positive predictive value was 87.5% (7/8) and the negative predictive value was 100% (1 199/1 199). The average Z value for diagnosing T18 was 6.593+ 2.352, 95%CI was 4.418~8.768, the sensitivity was 100% (5/5), the specificity was 99.83% (1 200/1 202), the missed diagnosis rate was 0 (0/5) , the misdiagnosis rate was 0.17% (2/1 202), the accuracy rate was 99.83% (1 205/1 207), the positive predictive value was 71.43% (5/7) and the negative predictive value was 100% (1 200/1 200). Conclusions NIPT had the advantage of speed, safety and high accuracy. It was con- sistent with karyotype analysis and has value in prenatal diagnosis.
出处 《分子诊断与治疗杂志》 2018年第2期96-102,共7页 Journal of Molecular Diagnostics and Therapy
关键词 无创性产前检测技术 胎儿染色体非整倍体异常 下一代测序 胎儿游离DNA Non-invasive prenatal testing Fetal abnormal chromosomal aneuploidy Next-genera-tion sequencing Cell-free fetal DNA
  • 相关文献

参考文献4

二级参考文献62

  • 1Evans M I, Wapner R J. Invasive prenatal diagnostic procedures 2005[J]. Sernin Perinatol, 2005,29(4): 215- 218.
  • 2Lo Y M, Corbetta N, Chamberlain P F, et al. Presence of fetal DNA in maternal plasma and serum[J]. Lancet, 1997,350(9076):485-487.
  • 3Sanger F, Nicklen S, Coulson A R. DNA sequencing with chain-terminating inhibitors[J]. Proc Natl Acad Sci U S A, 1977,74(12):5463-5467.
  • 4Maxam A M, Gilbert W. A new method for sequencing DNA[J]. Proc Natl Acad Sci U S A, 1977, 74(2):560-564.
  • 5Pareek C S, Smoczynski R, Tretyn A. Sequencing technologies and genome sequencing[J]. J Appl Genet, 2011,52(4):413-435.
  • 6Bianchi D W. Circulating fetal DNA: its origin and diagnostic potential-a review [J]. Placenta, 2004,25 Suppl A: S93-S101.
  • 7Alberry M, Maddocks D, Jones M, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confLrrnation that the origin is the trophoblast[J]. Prenat Diagn, 2007,27(5):415-418.
  • 8Chim S S, Tong Y K, Chiu R W, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma[J]. Proc Natl Acad Sci U S A, 2005, 102(41):14753-14758.
  • 9Lun F M, Chiu R W, Allen C K, et al. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma[J]. Clin Chem, 2008, 54 (10): 1664-1672.
  • 10Illanes S, Denbow M, Kailasam C, et al. Early detection of cell-free fetal DNA in maternal plasma[J]. Early Hum Dev, 2007,83(9):563-566.

共引文献65

同被引文献87

引证文献9

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部